Asset Allocation

As of June 30, 2026.
Type % Net
Cash -3.27%
Stock 17.58%
Bond 73.92%
Convertible 0.00%
Preferred 0.00%
Other 11.77%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 132.4%    % Emerging Markets: 11.33%    % Unidentified Markets: -43.72%

Americas 136.2%
125.0%
Canada 0.00%
United States 125.0%
11.25%
Brazil 1.96%
Chile 0.08%
Colombia 1.96%
Mexico 0.04%
Peru 4.17%
As of June 30, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 6.72%
United Kingdom 1.02%
2.55%
France 0.00%
Germany 0.00%
Ireland 1.91%
Netherlands 0.01%
Switzerland 0.20%
0.30%
Turkey 0.10%
2.85%
Egypt 0.14%
Nigeria 0.02%
Qatar 0.07%
South Africa 2.14%
United Arab Emirates 0.34%
Greater Asia 0.78%
Japan 0.64%
0.00%
Australia 0.00%
0.04%
Singapore 0.04%
0.09%
Indonesia 0.05%
Kazakhstan 0.04%
Unidentified Region -43.72%

Bond Credit Quality Exposure

AAA --
AA --
A --
BBB --
BB --
B --
Below B --
    CCC --
    CC --
    C --
    DDD --
    DD --
    D --
Not Rated --
Not Available --
Short Term --
No Data Available
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
23.89%
Materials
1.39%
Consumer Discretionary
12.15%
Financials
8.95%
Real Estate
1.39%
Sensitive
62.54%
Communication Services
7.37%
Energy
2.27%
Industrials
6.58%
Information Technology
46.32%
Defensive
11.79%
Consumer Staples
3.35%
Health Care
6.77%
Utilities
1.67%
Not Classified
1.77%
Non Classified Equity
1.77%
As of June 30, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of June 30, 2026
Type % Net
Government 21.20%
Corporate 6.73%
Securitized 72.07%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term --
Less than 1 Year --
Intermediate --
1 to 3 Years --
3 to 5 Years --
5 to 10 Years --
Long Term --
10 to 20 Years --
20 to 30 Years --
Over 30 Years --
Other --
No Data Available
View Bond Maturity Exposure
Start Trial